Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — FY2021 Earnings Presentation
17 slides from Amrutanjan Health Care's earnings presentation, May 27, 2021
Slide 1: Exchange cover letter for investor presentation
DocuSign Envelope ID: 04CC16B2-CB53-40C1-9F7A-286D913D39D5 ‘alth ES AHCL/ SE/ 14/2021-22 May 27 2021 The National Stock Exchange of BSE Limited IndiaLimited Department of Corporate Services “Exchange Plaza”, C-1, Block G 1st Floor, Bandra-Kurla Complex, Bandra (E) PJ. Towers, Dalal Street, Mumbai 40
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation – Quarter & Year Ended 31st March 2021 Date: 27th May 2021
Slide 3: Contents
Contents a. Business Update b. FY21 Performance c. Q4 FY21 Performance d. Way Forward Investor Presentation | Quarter & Year Ended 31st March 2021 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter & Year Ended 31st March 2021 3
Slide 5: Business Update
Business Update • Despite restrictions for field force during lockdown, our wholesale channel was picking up. This shows our Brand strength. • The increase in purchase volume by the distributors has contributed to the growth factor. • Consumers’ current preference of Balms over Tablets remains to be
Slide 6: Business Update
Business Update • Cash reserve as on 31st March 2021 is at Rs.191 crs (Rs.105 crs as on 31st March 2020) • Continue to be a ”No debt company” Investor Presentation | Quarter & Year Ended 31st March 2021 5
Slide 7: FY21 Performance
FY21 Performance Investor Presentation | Quarter & Year Ended 31st March 2021 6
Slide 8: Financials – FY21
Financials – FY21 (Rs. in Crores) Gross Sales Profit Before Tax 367.78 288.92 81.90 34.45 FY21 FY20 FY21 FY20 Growth: 27.29% Growth: 137.74% Gross Sales - E Comm. Profit After Tax 4.43 61.19 1.58 25.08 FY21 FY20 FY21 FY20 Growth: 180.38% Growth: 143.98% Investor Presentation | Quarter & Year Ended 3
Slide 9: Financials – FY21 – OTC Division
Financials – FY21 – OTC Division (Rs. in Crores) Gross Sales - OTC Costs: 346.75 266.05 • OTC sales has grown by 30.33% for FY21 even though in Q1 sales was affected due to Covid 19 lockdown. FY21 FY20 • Key raw material prices including Growth: 30.33% Menthol are lower when compared to FY20. Gross
Slide 10: Financials – FY21 – Beverage Division
Financials – FY21 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 20.45 Costs: 19.51 • Gross Margin has improved by 855 basis points when FY21 FY20 compared to FY20 mainly due Growth: -4.60% to product mix. Gross Sales - Electro Plus • Advertisement spends is 12.82 Rs.3.10 cr for FY21 ag
Slide 11: Key Financial Ratios
Key Financial Ratios Return on Capital Employed % Operating Profit Margin (%) 30.00% 40.00% 37.09% 24.76% 25.00% 35.00% 30.00% 20.00% 25.00% 20.85% 13.26% 15.00% 20.00% 15.00% 10.00% 10.00% 5.00% 5.00% 0.00% 0.00% FY21 FY20 FY21 FY20 Debtors Turnover Ratio Inventory Turnover Ratio 16.00 15.09 16.17
Slide 12: Q4 FY21 Performance
Q4 FY21 Performance Investor Presentation | Quarter & Year Ended 31st March 2021 11
Slide 13: Financials – Q4 FY21
Financials – Q4 FY21 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 104.74 13.71 10.23 10.64 7.89 66.20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Growth: 58.22% Growth: 28.85% Growth: 29.66% Investor Presentation | Quarter & Year Ended 31st March 2021 12
Slide 14: Financials – Q4 FY21
Financials – Q4 FY21 (Rs. in Crores) Gross Sales - OTC Gross Sales - Beverages 94.31 9.88 59.30 6.41 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Growth: 59.04% Growth: 54.13% Gross Sales - Comfy Gross Sales - Electro Plus 14.74 6.78 7.43 3.84 Q4 FY21 Q4 FY20 Q4 FY21 Q4 FY20 Growth: 98.38% Growth: 76.56% Investo
Slide 15: Way Forward
Way Forward Investor Presentation | Quarter & Year Ended 31st March 2021 14
Slide 16: Way Forward
Way Forward We remain focused on executing our key priorities: • Expand distribution • Grow E-Commerce vertical • Strengthen Beverage business • Costs control Investor Presentation | Quarter & Year Ended 31st March 2021 15
Slide 17: Investor Presentation | Quarter & Year Ended 31st March 2021
Investor Presentation | Quarter & Year Ended 31st March 2021 16
Amrutanjan Health Care — FY2021 Earnings Presentation on 6ix